Recombinant Brucella abortus biovar 1 Immunogenic membrane protein YajC (yajC)

What is YajC protein and how was it initially identified in Brucella abortus?

YajC is an immunogenic membrane protein identified in Brucella abortus through screening a genomic library of B. abortus strain 2308 for antigens that react with immunoglobulin G2a (IgG2a) antibodies from BALB/c mice vaccinated with B. abortus RB51. This screening approach specifically targeted proteins that could potentially stimulate a T-helper 1 (Th1) immune response, as IgG2a subisotype antibodies are indicative of such responses . The yajC gene was identified on a positive recombinant clone (clone MCB68) containing an insert of 2.6 kb. Nucleotide sequence analysis revealed two open reading frames (ORFs), with the first ORF encoding YajC and the second encoding SecD .

What is the genomic organization and sequence homology of Brucella abortus yajC?

The yajC gene in B. abortus is positioned adjacent to the secD gene, similar to the genomic organization found in several other bacterial species . Nucleotide sequence analysis of the clone containing yajC revealed significant sequence homology with YajC proteins from other bacterial species. This conservation suggests evolutionarily preserved functions across different bacterial genera. The close proximity of yajC to secD indicates potential functional relationships between these two proteins, possibly in protein secretion or membrane integrity maintenance .

What is the relationship between YajC and bacterial virulence in Brucella infections?

While YajC itself has not been directly characterized as a primary virulence factor like some other Brucella components (e.g., cyclic β-1,2-glucan), its immunogenic properties suggest potential involvement in host-pathogen interactions . Unlike classic virulence determinants such as toxins, pili, fimbria, and plasmids that Brucella lacks, YajC represents one of the antigenic components that may contribute to the bacterium's ability to establish intracellular infection . The protein appears to be expressed during infection and stimulates both humoral and cell-mediated immune responses, indicating its accessibility to the host immune system during natural infection .

What are the recommended methods for cloning and expressing recombinant Brucella abortus YajC?

Based on published research protocols, the following methodology is recommended for cloning and expressing YajC:

• PCR amplification of the yajC gene from B. abortus genomic DNA (strain 2308 has been successfully used)

• Design of primers with engineered restriction sites for directional cloning

• Expression in E. coli using expression vectors such as pMalP2 or pMalC2 (New England Biolabs)

• Expression as a fusion protein with maltose binding protein (MBP) at the amino terminus

• Purification by affinity chromatography using amylose resin

The PCR conditions used successfully include: 10 mM Tris-HCl (pH 9.0) buffer and appropriate cycling parameters. After amplification, the PCR product can be digested with appropriate restriction enzymes and ligated into the expression vector .

How can recombinant YajC protein be purified to maintain its immunogenic properties?

Purification of recombinant YajC protein while preserving its immunogenic properties requires careful consideration of several factors:

• Expression as an MBP fusion protein significantly improves solubility and facilitates purification via affinity chromatography with amylose resin

• After binding to amylose resin, washing steps should be performed to remove contaminants

• Elution using maltose (typically 10 mM) in an appropriate buffer

• If needed, the MBP tag can be removed using a specific protease (depending on the vector design)

• Further purification can be achieved through size exclusion chromatography

Researchers should verify protein purity via SDS-PAGE and confirm immunoreactivity through Western blot analysis using sera from Brucella-infected or vaccinated animals .

What expression systems have been validated for overexpression of functional YajC protein?

The E. coli expression system has been effectively validated for YajC protein production. Specifically, expression vectors pMalP2 and pMalC2 (New England Biolabs) have proven successful for producing recombinant YajC as a fusion protein with MBP . For expression in Brucella itself, broad-host-range vectors such as pBBR1MCS with chloramphenicol resistance have been used successfully. This system allowed for the introduction of the yajC gene along with its putative promoter into B. abortus RB51, creating strain RB51/pBByajC . This dual approach provides flexibility depending on research objectives - whether studying the protein's biochemical properties (E. coli system) or its functional role within Brucella (homologous expression).

What type of immune response does YajC protein stimulate in animal models?

YajC protein stimulates both humoral and cell-mediated immune responses in mice. Specifically:

• Humoral response: Mice vaccinated with B. abortus strains (RB51, strain 19, strain 2308, or B. melitensis RM1) produce antibodies against YajC, demonstrating its immunogenicity .

• Cell-mediated response: Splenocytes from mice vaccinated with B. abortus RB51, when stimulated in vitro with recombinant MBP-YajC fusion protein, showed:

  • Cellular proliferation

  • Production of gamma interferon (IFN-γ)

  • Absence of interleukin-4 (IL-4) production

This cytokine profile (IFN-γ positive, IL-4 negative) is characteristic of a Th1-biased immune response, which is considered protective against intracellular pathogens like Brucella. This finding is significant as it demonstrates YajC's ability to stimulate the type of immune response needed for protection against brucellosis .

How does the YajC-specific immune response compare to other Brucella immunogens?

While the search results don't provide direct comparative data between YajC and other specific Brucella immunogens, they do offer context for understanding its relative importance:

• YajC induces both antibody production and cell-mediated immunity with a Th1 bias (IFN-γ production), similar to other protective Brucella antigens .

• The study cited in the search results was the first to demonstrate YajC's involvement in immune responses to an infectious agent, highlighting its novel status as an immunogen .

• Unlike some other Brucella components such as LPS that may inhibit IFN-γ secretion and promote IL-10 production (potentially subverting protective immunity), YajC appears to stimulate a more protective Th1-biased response .

• Other Brucella proteins, such as BP26, BLS, and various Omps (outer membrane proteins), have also been proven highly immunogenic, but direct comparisons with YajC would require further targeted studies .

What is the potential of YajC as a component for subunit vaccine development against brucellosis?

YajC shows several characteristics that make it a promising candidate for inclusion in subunit vaccine development against brucellosis:

• It stimulates a Th1-biased immune response characterized by IFN-γ production without IL-4, which is considered protective against intracellular pathogens like Brucella .

• The protein is recognized by antibodies from mice infected with different Brucella strains, suggesting broad immunogenic potential across Brucella infections .

• YajC's ability to induce cellular proliferation in splenocytes from vaccinated animals indicates potential for memory response development, a critical feature for vaccine efficacy .

• Compared to attenuated live vaccines like B. abortus S19 that retain some virulence, a subunit approach using proteins like YajC could potentially offer improved safety profiles while maintaining protective immunogenicity .

The development of a YajC-based subunit vaccine would need to address several considerations, including appropriate adjuvant selection to enhance Th1 responses, optimal delivery methods, and combination with other immunogenic Brucella proteins for comprehensive protection .

How might YajC contribute to Brucella's intracellular survival mechanisms?

While the direct role of YajC in Brucella's intracellular survival is not fully elucidated in the provided search results, several hypotheses can be formulated based on available information:

• YajC's genomic proximity to secD suggests potential involvement in protein secretion or membrane integrity systems that might influence bacterial adaptation to intracellular environments .

• Unlike some Brucella virulence factors that actively suppress protective immunity (such as prpA, Btp1/TcpB, and LPS that can block IFN-γ secretion while promoting IL-10 production), YajC appears to stimulate protective immunity, suggesting it may not directly function as a virulence factor for immune evasion .

• Brucella employs multiple mechanisms to evade innate immunity, such as modifying PAMPs to avoid recognition by TLRs, and possessing atypical LPS that affects complement activation. YajC could potentially play indirect roles in these processes through its membrane-associated functions .

Further research using YajC knockout mutants, similar to studies done with cyclic β-1,2-glucan synthetase mutants, would be valuable to determine if YajC deficiency affects intracellular multiplication or persistence in cellular and animal models .

What are the methodological approaches for studying YajC's role in host-pathogen interactions?

Several methodological approaches can be employed to investigate YajC's role in host-pathogen interactions:

• Generation of yajC knockout mutants:

  • Create deletion mutants in virulent (e.g., B. abortus 2308) and attenuated (e.g., B. abortus S19) strains

  • Evaluate changes in virulence, intracellular survival, and host immune responses

  • Compare with wild-type strains in cellular infection models and animal studies

• Cell culture infection models:

  • Infect macrophages and other relevant cell types with wild-type and yajC-deficient Brucella

  • Measure intracellular survival and replication rates

  • Analyze cytokine production profiles and cellular activation markers

• Immunological assays:

  • Stimulate splenocytes from infected/vaccinated animals with purified YajC

  • Measure T-cell proliferation and cytokine production (particularly IFN-γ, TNF-α, IL-12)

  • Evaluate the balance of Th1/Th2 responses through cytokine profiling

• In vivo challenge studies:

  • Immunize animals with recombinant YajC (with appropriate adjuvants)

  • Challenge with virulent Brucella strains

  • Assess protection through spleen colonization reduction and immune correlates of protection

What controls should be included when evaluating the immunogenicity of recombinant YajC protein?

When evaluating YajC immunogenicity, the following controls are essential:

• Protein-specific controls:

  • Purified MBP alone (when using MBP-YajC fusion proteins) to distinguish responses to YajC from those to the fusion partner

  • Heat-denatured YajC to assess the importance of conformational epitopes

  • Other Brucella proteins to compare immunogenicity profiles

• Immunological assay controls:

  • Splenocytes from unvaccinated/uninfected animals (negative control)

  • Splenocytes stimulated with known Brucella antigens or whole-cell lysates (positive control)

  • Measurement of multiple cytokines (IFN-γ, IL-4, IL-10, TNF-α) to characterize the type of immune response

• Animal model controls:

  • Different mouse strains to account for genetic variability in immune responses

  • Time-course sampling to capture the dynamics of immune responses

  • Dose-dependent studies to determine optimal antigen concentrations

In the study examining YajC immunogenicity, researchers appropriately used splenocytes from saline-inoculated mice as negative controls and included MBP alone as a protein control when evaluating responses to the MBP-YajC fusion protein .

How can researchers address solubility and stability issues with recombinant YajC production?

Researchers may encounter solubility and stability issues when producing recombinant YajC. These challenges can be addressed through several approaches:

• Fusion protein strategies:

  • The MBP fusion approach has proven successful for YajC expression and significantly enhances solubility

  • Alternative fusion partners (e.g., GST, SUMO, thioredoxin) could be explored if MBP fusion is suboptimal

  • Inclusion of appropriate linker sequences between YajC and fusion partners

• Expression optimization:

  • Testing different E. coli strains (BL21, Rosetta, Arctic Express)

  • Optimizing induction conditions (temperature, IPTG concentration, induction time)

  • Using enriched media formulations for improved expression

• Purification considerations:

  • Including protease inhibitors during extraction and purification

  • Testing different buffer compositions to enhance stability

  • Employing gentle elution conditions to maintain protein integrity

  • Storage with glycerol or other stabilizing agents at appropriate temperatures

• Protein quality assessment:

  • Circular dichroism to verify proper folding

  • Size exclusion chromatography to confirm monomeric status

  • Western blotting with conformation-specific antibodies to assess native structure

What are the most promising future research avenues for understanding YajC's role in Brucella pathogenesis?

Several promising research directions could expand our understanding of YajC's role in Brucella pathogenesis:

• Structural biology approaches:

  • Determining the three-dimensional structure of YajC through X-ray crystallography or cryo-EM

  • Identifying potential interaction partners through structural modeling and protein-protein interaction studies

  • Mapping immunodominant epitopes to understand the molecular basis of its immunogenicity

• Comparative genomics and evolution:

  • Analyzing YajC sequence conservation across Brucella species and biovars

  • Investigating functional conservation with YajC homologs in other bacterial pathogens

  • Assessing selective pressure on yajC sequences to identify functionally important regions

• Systems biology integration:

  • Transcriptomic analysis to determine yajC expression patterns during different stages of infection

  • Proteomics studies to identify YajC interaction networks

  • Metabolomic impacts of YajC function on bacterial physiology

• Translational applications:

  • Evaluation of YajC as a diagnostic antigen for brucellosis detection

  • Assessment of YajC in combinatorial subunit vaccine formulations

  • Exploration of YajC-based immunotherapeutic approaches

The continued study of YajC within the broader context of Brucella virulence and immune evasion mechanisms will provide valuable insights for both fundamental understanding of host-pathogen interactions and applied vaccine development efforts .